Eben Tessari Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Eben Tessari is CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 16,666 shares of KNSA, which is worth approximately $671,973. The most recent transaction as insider was on Dec 15, 2025, when has been sold 12,048 shares (Class A Ordinary Share) at a price of $41.56 per share, resulting in proceeds of $500,714. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.7K

51.77% 3M change

82.64% 12M change

Total Value Held $671,973

Eben Tessari Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2025	SELL Open market or private sale	$500,714 $41.56 p/Share	12,048 Reduced 41.96%	16,666 Class A Ordinary Share
Dec 15 2025	BUY Exercise of conversion of derivative security	$52,980 $8.83 p/Share	6,000 Added 17.28%	28,714 Class A Ordinary Share
Nov 26 2025	SELL Open market or private sale	$8,578 $42.89 p/Share	200 Reduced 0.87%	22,714 Class A Ordinary Share
Nov 26 2025	BUY Exercise of conversion of derivative security	$4,578 $22.89 p/Share	200 Added 0.87%	22,914 Class A Ordinary Share
Nov 17 2025	SELL Open market or private sale	$507,404 $40.69 p/Share	12,470 Reduced 35.44%	22,714 Class A Ordinary Share
Nov 17 2025	BUY Exercise of conversion of derivative security	$57,395 $8.83 p/Share	6,500 Added 15.59%	35,184 Class A Ordinary Share
Oct 14 2025	SELL Open market or private sale	$467,757 $37.82 p/Share	12,368 Reduced 30.13%	28,684 Class A Ordinary Share

Oct 14 2025	BUY Exercise of conversion of derivative security	$57,395 $8.83 p/Share	6,500 Added 13.67%	41,052 Class A Ordinary Share
Sep 29 2025	SELL Open market or private sale	$1,609,860 $38.33 p/Share	42,000 Reduced 54.86%	34,552 Class A Ordinary Share
Sep 29 2025	BUY Exercise of conversion of derivative security	$752,640 $17.92 p/Share	42,000 Added 35.43%	76,552 Class A Ordinary Share
Sep 15 2025	SELL Open market or private sale	$602,372 $36.73 p/Share	16,400 Reduced 32.19%	34,552 Class A Ordinary Share
Sep 15 2025	BUY Exercise of conversion of derivative security	$57,395 $8.83 p/Share	6,500 Added 11.31%	50,952 Class A Ordinary Share
Sep 05 2025	SELL Open market or private sale	$477,451 $35.66 p/Share	13,389 Reduced 23.15%	44,452 Class A Ordinary Share
Sep 05 2025	BUY Exercise of conversion of derivative security	$207,797 $15.52 p/Share	13,389 Added 18.8%	57,841 Class A Ordinary Share
Sep 04 2025	SELL Open market or private sale	$3,028,825 $35.52 p/Share	85,271 Reduced 65.73%	44,452 Class A Ordinary Share
Sep 04 2025	BUY Exercise of conversion of derivative security	$1,322,553 $15.51 p/Share	85,271 Added 39.66%	129,723 Class A Ordinary Share
Sep 03 2025	SELL Open market or private sale	$535,730 $35.5 p/Share	15,091 Reduced 25.34%	44,452 Class A Ordinary Share
Sep 03 2025	BUY Exercise of conversion of derivative security	$234,061 $15.51 p/Share	15,091 Added 20.22%	59,543 Class A Ordinary Share
Sep 02 2025	SELL Payment of exercise price or tax liability	$32,566 $34.28 p/Share	950 Reduced 2.09%	44,452 Class A Ordinary Share
Sep 02 2025	BUY Exercise of conversion of derivative security	-	1,964 Added 4.15%	45,402 Class A Ordinary Share
Sep 01 2025	SELL Payment of exercise price or tax liability	$101,206 $33.49 p/Share	3,022 Reduced 6.5%	43,438 Class A Ordinary Share
Sep 01 2025	BUY Exercise of conversion of derivative security	-	6,245 Added 11.85%	46,460 Class A Ordinary Share
Aug 18 2025	SELL Open market or private sale	$552,582 $34.11 p/Share	16,200 Reduced 28.72%	40,215 Class A Ordinary Share
Aug 18 2025	BUY Exercise of conversion of derivative security	$57,395 $8.83 p/Share	6,500 Added 10.33%	56,415 Class A Ordinary Share
Aug 05 2025	SELL Open market or private sale	$4,650,499 $33.55 p/Share	138,614 Reduced 73.52%	49,915 Class A Ordinary Share

Eben Tessari

CHIEF OPERATING OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account